What Researchers Did
Researchers reviewed strategies to overcome tumour hypoxia and exploit this unique tumour environment for targeted gene therapy, focusing on the latest developments in cancer gene therapy.
What They Found
They found that tumour hypoxia negatively impacts treatment outcomes for radiation, chemotherapy, and surgery. Two main strategies identified include increasing oxygen delivery and exploiting hypoxia for targeted therapy, such as using hypoxia-inducible factor (HIF) and hypoxia responsive elements (HREs) for selective gene activation.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
As a review article, this study synthesizes existing knowledge rather than presenting new experimental data or clinical trial results.